RS51317B - Postupci pravljenja 3-0 zaštićenih morfinona i 3-0 zaštićenih morfinon dienol karboksilata - Google Patents

Postupci pravljenja 3-0 zaštićenih morfinona i 3-0 zaštićenih morfinon dienol karboksilata

Info

Publication number
RS51317B
RS51317B RSP-2010/0064A RSP20100064A RS51317B RS 51317 B RS51317 B RS 51317B RS P20100064 A RSP20100064 A RS P20100064A RS 51317 B RS51317 B RS 51317B
Authority
RS
Serbia
Prior art keywords
protected
formula
making
methods
compound
Prior art date
Application number
RSP-2010/0064A
Other languages
English (en)
Inventor
Andreas Stumpf
Original Assignee
Euro-Celtique S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34860329&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=RS51317(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Euro-Celtique S.A. filed Critical Euro-Celtique S.A.
Publication of RS51317B publication Critical patent/RS51317B/sr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D489/00Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/02Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with oxygen atoms attached in positions 3 and 6, e.g. morphine, morphinone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/22Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Catalysts (AREA)
  • Steroid Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

Postupak za dobijanje jedinjenja formule (III):koji se sastoji od:(a) reagovanja jedinjenja formule (I):pod pogodnim uslovima, u prisustvu smeše jedinjenja formule R1SR2 i trihloroizocijanurinske kiseline, tako da se dobije jedinjenje formule (II):ib) reagovanja jedinjenja formule (II) pod povoljnim uslovima sa prvom bazom i agensom za acilovanje, formule R4(C(O)OC(O)R4 ili R4C(O)X, tako da se dobije jedinjenje formule (III), u kome su:R1 i R2 svaki nezavisno, -(C1-C20)alkil, -(C3-C8)cikloalkil ili -fenil;R3 je neka zaštitna grupa;R4 je –(C1-C10)alkil; iX je –Cl, Br ili –I.Prijava sadrži još 22 patentna zahteva.
RSP-2010/0064A 2004-02-06 2005-02-04 Postupci pravljenja 3-0 zaštićenih morfinona i 3-0 zaštićenih morfinon dienol karboksilata RS51317B (sr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US54271104P 2004-02-06 2004-02-06

Publications (1)

Publication Number Publication Date
RS51317B true RS51317B (sr) 2010-12-31

Family

ID=34860329

Family Applications (2)

Application Number Title Priority Date Filing Date
RSP-2008/0553A RS50663B (sr) 2004-02-06 2005-02-04 Postupci za dobijanje 3-o-zaštićenih morfinona i 3-o-zaštićenih morfinon dienol karboksilata
RSP-2010/0064A RS51317B (sr) 2004-02-06 2005-02-04 Postupci pravljenja 3-0 zaštićenih morfinona i 3-0 zaštićenih morfinon dienol karboksilata

Family Applications Before (1)

Application Number Title Priority Date Filing Date
RSP-2008/0553A RS50663B (sr) 2004-02-06 2005-02-04 Postupci za dobijanje 3-o-zaštićenih morfinona i 3-o-zaštićenih morfinon dienol karboksilata

Country Status (34)

Country Link
US (6) US8003793B2 (sr)
EP (3) EP2194059A3 (sr)
JP (1) JP4963968B2 (sr)
KR (4) KR20070108956A (sr)
CN (1) CN1918168B (sr)
AP (1) AP2006003716A0 (sr)
AT (2) ATE406372T1 (sr)
AU (1) AU2005212258B2 (sr)
BR (1) BRPI0506607B8 (sr)
CA (2) CA2555215C (sr)
CR (1) CR8590A (sr)
CY (2) CY1108506T1 (sr)
DE (2) DE602005018265D1 (sr)
DK (2) DK1864987T3 (sr)
EA (2) EA012905B1 (sr)
EC (1) ECSP066824A (sr)
ES (2) ES2313299T3 (sr)
GE (1) GEP20084454B (sr)
HK (2) HK1103071A1 (sr)
HR (2) HRP20080618T3 (sr)
IL (2) IL177281A (sr)
MA (1) MA28346A1 (sr)
MX (1) MXPA06008931A (sr)
NO (2) NO20063989L (sr)
NZ (2) NZ565355A (sr)
PL (2) PL1711502T3 (sr)
PT (2) PT1711502E (sr)
RS (2) RS50663B (sr)
SG (1) SG150500A1 (sr)
SI (2) SI1711502T1 (sr)
TN (1) TNSN06248A1 (sr)
UA (2) UA88646C2 (sr)
WO (1) WO2005077957A2 (sr)
ZA (1) ZA200606252B (sr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2194059A3 (en) 2004-02-06 2010-09-22 Euro-Celtique S.A. Methods for making 3-O-protected morphinones and 3-O-protected morphinone dienol carboxylates
CA2663909A1 (en) * 2006-09-20 2008-03-27 Mallinckrodt Inc. Preparation of substituted morphinan-6-ones and salts and intermediates thereof
US9040726B2 (en) * 2007-03-06 2015-05-26 Mallinckrodt Llc Process for the preparation of quaternary N-alkyl morphinan alkaloid salts
CA2707757C (en) * 2007-03-06 2017-01-03 Peter X. Wang Process for the preparation of quaternary n-alkyl morphinan alkaloid salts
AU2009251427B2 (en) 2008-05-27 2014-05-22 SpecGx LLC Processes and compounds for the preparation of normorphinans
WO2010028004A2 (en) 2008-09-03 2010-03-11 Mallinckrodt Inc. Substituted berbines and processes for their synthesis
BR112012028656A2 (pt) 2010-05-10 2016-08-09 Euro Celtique Sa combinação de grânulos carregados ativos com ativos adicionais
CA2798884C (en) 2010-05-10 2016-09-13 Euro-Celtique S.A. Manufacturing of active-free granules and tablets comprising the same
AR083150A1 (es) 2010-05-10 2013-02-06 Euro Celtique Sa Composiciones farmaceuticas que comprenden hidromorfona y naloxona
DE112014005175T5 (de) 2013-11-13 2016-07-21 Euro-Celtique S.A. Hydromorphon und Naloxon für die Behandlung von Schmerzen und Opioid-Darm-Dysfunktions-Syndrom
MX2018001968A (es) * 2015-09-30 2018-11-09 Fujifilm Finechemicals Co Ltd Metodo de produccion de compuestos organicos.

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2654756A (en) * 1949-10-20 1953-10-06 Mallinckrodt Chemical Works Process of preparing codeinone, dihydrocodeinone, and dihydromorphinone
DE902257C (de) 1951-07-17 1954-01-21 Knoll Ag Verfahren zur Herstellung von Acylderivaten der Enolform des Codeinons
GB1495271A (en) * 1974-04-10 1977-12-14 Macfarlan Smith Ltd Dehydrohalogenation of codeinone derivatives
US4472253A (en) * 1981-08-17 1984-09-18 The Florida Board Of Regents On Behalf Of The Florida State University Process for the preparation of an N-substituted 3-O-alkyl-14-hydroxynormorphinone derivative
US5112975A (en) * 1984-03-27 1992-05-12 Mallinckrodt Specialty Chemicals Company Preparation of noroxymorphone from morphine
SE9003665D0 (sv) * 1990-11-16 1990-11-16 Kabivitrum Ab Morphine prodrugs
GB9116909D0 (en) * 1991-08-06 1991-09-18 Salford Ultrafine Chem & Res Morphine derivatives
US5821374A (en) * 1995-11-21 1998-10-13 Hoffmann-La Roche Inc. Process for the oxidation of alcohols
US5869669A (en) * 1996-07-26 1999-02-09 Penick Corporation Preparation of 14-hydroxynormorphinones from normorphinone dienol acylates
GB9713703D0 (en) * 1997-06-30 1997-09-03 Johnson Matthey Plc Preparation of opiates
US6177567B1 (en) * 1999-10-15 2001-01-23 Boehringer Ingelheim Chemicals, Inc. Method for preparing oxycodone
US6596877B2 (en) * 2001-10-17 2003-07-22 Novartis Ag Accelerated process for preparing O-methyl phenols, N-methyl heteroaromatic compounds, and methylated aminophenols
EP2194059A3 (en) 2004-02-06 2010-09-22 Euro-Celtique S.A. Methods for making 3-O-protected morphinones and 3-O-protected morphinone dienol carboxylates

Also Published As

Publication number Publication date
WO2005077957A3 (en) 2006-05-04
US20120225902A1 (en) 2012-09-06
MXPA06008931A (es) 2007-01-26
US20150239898A1 (en) 2015-08-27
KR100921695B1 (ko) 2009-10-15
WO2005077957A2 (en) 2005-08-25
AU2005212258A1 (en) 2005-08-25
ATE406372T1 (de) 2008-09-15
EP1864987A2 (en) 2007-12-12
CA2555215A1 (en) 2005-08-25
IL177281A (en) 2012-02-29
TNSN06248A1 (fr) 2007-12-03
KR20070108956A (ko) 2007-11-13
US20120022259A1 (en) 2012-01-26
NO20150276L (no) 2006-10-31
EP1864987B1 (en) 2009-12-09
US8685996B2 (en) 2014-04-01
KR20090089486A (ko) 2009-08-21
US9670218B2 (en) 2017-06-06
ECSP066824A (es) 2006-12-29
DE602005009321D1 (de) 2008-10-09
SG150500A1 (en) 2009-03-30
NO20063989L (no) 2006-10-31
AP2006003716A0 (en) 2006-08-31
CY1108506T1 (el) 2014-04-09
PL1711502T3 (pl) 2009-02-27
PT1711502E (pt) 2008-11-20
US8003793B2 (en) 2011-08-23
AU2005212258B2 (en) 2008-05-22
ATE451374T1 (de) 2009-12-15
EP1711502B1 (en) 2008-08-27
HRP20080618T3 (en) 2009-01-31
EP1711502A2 (en) 2006-10-18
EA016062B1 (ru) 2012-01-30
ES2338054T3 (es) 2010-05-03
IL205596A (en) 2011-11-30
EA200601394A1 (ru) 2006-12-29
US8975257B2 (en) 2015-03-10
CA2808199A1 (en) 2005-08-25
HK1119160A1 (en) 2009-02-27
ES2313299T3 (es) 2009-03-01
PL1864987T3 (pl) 2010-05-31
IL177281A0 (en) 2006-12-10
CR8590A (es) 2007-07-19
US20140171643A1 (en) 2014-06-19
BRPI0506607B1 (pt) 2018-01-16
SI1864987T1 (sl) 2010-04-30
MA28346A1 (fr) 2006-12-01
JP4963968B2 (ja) 2012-06-27
CA2808199C (en) 2015-10-27
KR20070117701A (ko) 2007-12-12
HRP20100123T1 (hr) 2010-04-30
NZ565355A (en) 2008-09-26
NO339083B1 (no) 2016-11-14
CA2555215C (en) 2013-05-21
RS50663B (sr) 2010-06-30
DE602005018265D1 (de) 2010-01-21
PT1864987E (pt) 2010-03-09
UA87833C2 (uk) 2009-08-25
DK1864987T3 (da) 2010-04-12
ZA200606252B (en) 2007-11-28
NZ548786A (en) 2008-08-29
CY1109838T1 (el) 2014-09-10
US8198444B2 (en) 2012-06-12
US20080146804A1 (en) 2008-06-19
CN1918168A (zh) 2007-02-21
SI1711502T1 (sl) 2009-02-28
BRPI0506607B8 (pt) 2021-05-25
EA012905B1 (ru) 2010-02-26
EA200801811A1 (ru) 2008-12-30
KR20070026401A (ko) 2007-03-08
HK1103071A1 (en) 2007-12-14
EP2194059A2 (en) 2010-06-09
CN1918168B (zh) 2011-04-27
DK1711502T3 (da) 2008-12-01
EP2194059A3 (en) 2010-09-22
GEP20084454B (en) 2008-08-10
UA88646C2 (uk) 2009-11-10
JP2007520563A (ja) 2007-07-26
KR101011460B1 (ko) 2011-01-28
EP1864987A3 (en) 2008-02-20
KR100921696B1 (ko) 2009-10-15
US20170233400A1 (en) 2017-08-17
BRPI0506607A (pt) 2007-05-02

Similar Documents

Publication Publication Date Title
RS51317B (sr) Postupci pravljenja 3-0 zaštićenih morfinona i 3-0 zaštićenih morfinon dienol karboksilata
CO6150145A2 (es) Derivados de aril/heterociclo/cicloalquil/cicloalquil fenil substituidos utiles como agentes inmunosupresores
RS50672B (sr) Postupak za pripremanje n-fenilpirazol-1-karboksamida
DK1678119T3 (da) Fremgangsmåde til fremstilling af 2-dihalogenacyl-3-amino-acrylsyreestere og 3-dihalogenmethyl-pyrazol-4-carboxylsyreestere
RU2005127626A (ru) Способ получения производных топирамата-антиконвульсантов
CO6231002A2 (es) Compuestos utiles como ligandos para tomar imagenes de inervacion cardiaca
CO6362007A2 (es) Derivados de azaspiranil-alquilcarbamatos de heterociclos de 5 eslabones, su preparación y su aplicación en terapeútica
HRP20041042A2 (en) Novel substituted sulfamate anticonvulsant derivatives
AR040963A1 (es) Compuestos que inhiben la adhesion celular mediada por integrina alfa 4, un procedimiento de preparacion y composicion farmaceutica que los contiene
EA200701176A1 (ru) Новые соединения нафталина, способ их получения и фармацевтические композиции, содержащие их
ES2422204T3 (es) Novedosos derivados de imidazolidin-2-ona como moduladores selectivos de receptor de andrógenos (SARMS)
GB0525673D0 (en) Organic compounds
RU2012123154A (ru) Способы лечения синдрома фибромиалгии
MY150047A (en) Method of producing 2'-deoxy-5-azacytidine (decitabine)
IL180428A0 (en) Novel flame-retardant polystyrenes
MEP24208A (en) Derivatives of dioxane-2-alkyl carbamates, preparation method thereof and application of same in therapeutics
MX2010003148A (es) Procedimiento para la preparacion de diamidas de acido sulfonico.
TW200604161A (en) Chemical process
AR057555A1 (es) Un inhibidor de fosfodiesterasa-4 4-oxo-1-(3-sustituido fenil-1,4-dihidro-1,8-naftiridin-3-carboxamida y un procedimiento de preparacion del mismo
RU2012142223A (ru) Пространственно-затрудненные амины
AR059613A1 (es) Proceso para la preparacion de compuestos de dibenzotiazepina
CN102029125B (zh) 双长链均三嗪类两性表面活性剂及其合成方法
RU2005114472A (ru) Полупроводниковое органическое соединение, способ его получения, его применение и электронный функциональный элемент
SG168482A1 (en) New chromene compounds, a process for their preparation and pharmaceutical compositions containing them
MX2012001675A (es) Procedimiento para preparar 2,4-dioxotetrahidrofuran-3-carboxilato s.